Amplia Therapeutics Limited

ASX:ATX.AX

0.068 (AUD) • At close March 12, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) AUD.

2024 Q42024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42013 Q42013 Q2
Omzet 2.0042.448-0.581.7691.2210.7630.6740.860.0340-00.051-0.0770.6570.6161.1821.4470.8170.0150.015000
Kosten van de omzet 0.3310.0430.0440.0290.0020.00200000.0790.0770.0220.080.0750.1310.1140.1360.1190.11900.1180.118
Brutowinst 1.6742.405-0.6241.741.2190.7610.6730.860.034-0-0.079-0.026-0.10.5770.5411.0511.3320.681-0.104-0.1040-0.118-0.118
Brutowinstmarge 0.8350.9821.0770.9840.9990.9980.99910.9880187.19-0.5111.2910.8780.8790.8890.9210.834-6.852-6.852000
Onderzoek- en ontwikkelingskosten 3.6112.1941.1583.5292.4711.3021.4610.750.7580.3130.5420.1361.1962.0293.1482.8883.3051.4421.0211.0210.3240.3870.387
Algemene en administratieve kosten 1.3891.2151.2050.9930.9040.7320.6340.5010.4060.4530.3940.4670.5380.8150.7310.7330.6280.6190.8010.8010.8730.3630.363
Verkoop- en marketingkosten 0.040.1580.3880.1280.1650.050.3510.1770.2050.1220.1470.0970.0340.1580.1440.1530.1420.1290.070.0700.1070.107
Verkoop-, algemene en administratieve kosten 1.4291.3731.5941.1211.0690.7820.9850.6780.6110.5750.5410.5640.5751.0451.0491.6410.8520.8950.8010.801-0.2140.470.47
Overige kosten -0.023000000000000000000.0150.015000
Bedrijfskosten 5.0163.5672.7524.653.542.0842.4461.4281.370.8891.0840.7011.7133.0894.1834.5474.1772.8542.7152.7150.111.291.29
Bedrijfsresultaat -3.342-3.61-2.796-4.679-3.542-2.085-2.446-1.429-1.37-0.889-1.163-0.727-1.813-2.512-3.642-3.496-2.844-2.173-2.699-2.699-2.044-1.515-1.515
Bedrijfsresultaat ratio -1.668-1.4744.822-2.644-2.901-2.735-3.632-1.661-40.03202,756.372-14.28523.517-3.821-5.914-2.957-1.966-2.661-178.107-178.107000
Totaal overige inkomsten en kosten netto -2.0210.0320.0460.039-0.0010-0.1620.0570.0020.0040.0110.0080.0110.0010.048-0.0040.0360.0380.0810.081-0.203-0.179-0.179
Inkomen voor belasting -5.364-3.578-2.751-4.64-3.542-2.085-2.444-1.371-1.368-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-2.619-2.619-2.248-1.694-1.694
Inkomen voor belasting ratio -2.676-1.4614.743-2.622-2.902-2.735-3.628-1.594-39.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615-172.787-172.787000
Belastingkosten -1.989-2.4480.58-1.728-1.221-0.763-0.674-0.86-0.034-000000000-0.081-0.0810.04300
Nettowinst -3.374-1.129-3.331-2.912-2.322-1.323-1.77-0.511-1.334-0.885-1.152-0.718-1.802-2.495-3.594-3.482-2.808-2.135-2.619-2.619-2.248-1.694-1.694
Nettowinstmarge -1.683-0.4615.743-1.646-1.902-1.735-2.628-0.594-38.98102,730.227-14.10323.379-3.796-5.836-2.945-1.941-2.615-172.787-172.787000
WPA (Winst Per Aandeel) -0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.13-0.13-0.174-0.1-0.1
Verwaterde WPA -0.017-0.006-0.017-0.015-0.014-0.011-0.016-0.006-0.018-0.017-0.028-0.019-0.08-0.11-0.16-0.17-0.15-0.12-0.13-0.13-0.174-0.1-0.1
EBITDA -3.441-1.118-2.669-2.88-3.54-2.084-2.443-1.428-1.37-0.885-1.162-0.726-1.808-2.496-3.622-3.478-2.793-1.656-1.844-1.844-1.264-0.742-0.742
EBITDA ratio -1.717-1.4574.746-2.628-2.9-2.733-3.631-1.661-40.0202,754.488-14.26923.454-3.797-5.882-2.942-1.93-2.028-121.689-121.689000